By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protea Biosciences today announced a worldwide licensing agreement with George Washington University for mass spectrometry-based technology.

The technology, called Laser Ablation Electrospray Ionization, or LAESI, can directly identify proteins, peptides, lipids, and metabolites in biological samples, including tissue, blood, urine, and single cells, Protea said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.